Analysis of Serum Inflammatory Markers in Infants Under 6 Months of Age with Non-Syndromic Moderate and Severe Hearing Loss Associated with GJB2 Gene Mutations
Medical Science Monitor · 2022
DOI: 10.12659/msm.938165 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Science Monitor, 2022. Verfasst von Xingang Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology - Head and Neck Surgery, Ningbo Women and Children's Hospital, Ningbo, Zhejiang, China (mainland). Hauptthemen laut MEDLINE: Hearing Loss, Deafness, Hearing Loss, Sensorineural. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND The GJB2 gene is reported to be the main hereditary factor responsible for non-syndromic hearing impairment in infants. Several kinds of hearing loss have been linked to elevated inflammatory markers. This study aimed to evaluate serum levels of IL-2, IL-4, IL-6, IL-10, IL-17, alpha-TNF, and γ-IFN and the severity of hearing loss. MATERIAL AND METHODS Ninety newborns were divided into 3 groups: severe hearing impairment (31 infants), moderate hearing impairment (30 infants), and normal hearing (29 infants). Hearing screening was performed using otoacoustic emissions test. Mutations of the GJB2 gene were detected with Sanger sequencing. The patients had DNFB1 mutation. Seven blood inflammatory markers were tested using Cytometric Bead Array. We performed the t test to examine differences in expression of 7 inflammatory markers between sexes in the groups. The correlation between indicators within groups was studied using the Pearson correlation test. Correlation of different indicators among groups was studied using the Spearman correlation test. RESULTS When compared among the 3 groups (severe, moderate hearing impairment, and normal hearing group), we found that IL-10 had a positive correlation with the severity of GJB2-associated hearing loss, which was statistically significant (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology - Head and Neck Surgery, Ningbo Women and Children's Hospital, Ningbo, Zhejiang, China (mainland).
- Department of Otorhinolaryngology - Head and Neck Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China (mainland).
- Department of Pediatrics, Ningbo Women and Children's Hospital, Ningbo, Zhejiang, China (mainland).
- Central Laboratory of Birth Defects Prevention and Control, Ningbo Women and Children's Hospital, Ningbo, Zhejiang, China (mainland).
- Department of Child Healthcare, Ningbo Women and Children's Hospital, Ningbo, Zhejiang, China (mainland).
Zitieren
APA
Zhang, X., Ma, Z., Zheng, J., Xu, H., Pan, J., & Lv, L. (2022). Analysis of Serum Inflammatory Markers in Infants Under 6 Months of Age with Non-Syndromic Moderate and Severe Hearing Loss Associated with GJB2 Gene Mutations. Medical Science Monitor. https://doi.org/10.12659/msm.938165
Vancouver
Zhang X, Ma Z, Zheng J, Xu H, Pan J, Lv L. Analysis of Serum Inflammatory Markers in Infants Under 6 Months of Age with Non-Syndromic Moderate and Severe Hearing Loss Associated with GJB2 Gene Mutations. Medical Science Monitor. 2022. doi:10.12659/msm.938165
BibTeX
@article{Zhang2022,
author = {Zhang, Xingang and Ma, Zhaoxin and Zheng, Jishan and Xu, Huiqing and Pan, Jiewen and Lv, Lanqiu},
title = {Analysis of Serum Inflammatory Markers in Infants Under 6 Months of Age with Non-Syndromic Moderate and Severe Hearing Loss Associated with GJB2 Gene Mutations},
journal = {Medical Science Monitor},
year = {2022},
doi = {10.12659/msm.938165}
}
EUVIMED